---
schema_version: "secwatch.filing_event.v1"
accession: "0001013762-24-001604"
form_type: "8-K"
ticker: "SXTP"
cik: "0001946563"
company_name: "60 DEGREES PHARMACEUTICALS, INC."
filed_at: "2024-07-26T23:59:59+00:00"
generated_at: "2026-05-31T16:03:09.213143+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# 60 Degrees Pharma awarded $311,862 U.S. Army contract for ARAKODA packaging validation

## Summary
- Awarded a fixed-price contract valued at $311,862 with U.S. Army Medical Materiel Development Activity for new bottle and replacement blister packaging of ARAKODA.
- Contract aims to facilitate commercial validation to ensure continued U.S. government procurement of malaria prevention drug ARAKODA.
- Q1 2024 ARAKODA net sales revenue increased 515% YoY to $105.7 thousand; company increased commercial batch size in Q1.

## SEC filing metadata
- accession: 0001013762-24-001604
- form_type: 8-K
- ticker: SXTP
- cik: 0001946563
- company_name: 60 DEGREES PHARMACEUTICALS, INC.
- filed_at: 2024-07-26T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1946563/000101376224001604/0001013762-24-001604-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1946563/000101376224001604/ea021010701-8k_60degrees.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001013762-24-001604
- JSON: https://secwatch.observer/filing/0001013762-24-001604.json
- Plain text: https://secwatch.observer/filing/0001013762-24-001604.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.